MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer. Επικοινωνία Submitted by Βασιλική Κωτού… on Τρί, 12/01/2020 - 13:32
